AYActive Study! A Physical Health Activity Intervention
NCT ID: NCT04601948
Last Updated: 2023-05-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
14 participants
INTERVENTIONAL
2019-11-06
2020-09-04
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
mHealth Physical Activity Intervention for Young Cancer Survivors
NCT04765241
Optimization of a mHealth Physical Activity Promotion Intervention With Mindful Awareness for AYAO (OPT2MOVE)
NCT05375162
Mobile Health Fitness Program for Adolescent and Young Adult Childhood Cancer Survivors
NCT02688192
Physical Activity Intervention for Lung Cancer Survivors
NCT00717795
Physical Activity Intervention for Hematopoietic Cell Transplant Recipients and Caregivers
NCT05208554
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intervention
Participants will receive a Fitbit activity monitor and access to the mHealth physical activity intervention for 6 weeks. The intervention will include regular motivational messages to encourage activity, a social media thread to provide social support, and a series of fun virtual walking races.
mHealth Activity Intervention
Eligible participants will receive a Fitbit activity monitor and access to our mHealth physical activity intervention for 6 weeks. The intervention will include regular motivational messages to encourage activity, a social media thread to provide social support, and a series of fun virtual walking races.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
mHealth Activity Intervention
Eligible participants will receive a Fitbit activity monitor and access to our mHealth physical activity intervention for 6 weeks. The intervention will include regular motivational messages to encourage activity, a social media thread to provide social support, and a series of fun virtual walking races.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Diagnosed between 13 and 39 years old
* Currently 3-24 months post-treatment (or in maintenance therapy)
* Receiving survivorship care at HCCC/UIHC
* In remission
* Physically able to walk without limitations
* Own a smartphone with a data plan that is also capable of receiving and sending texts
* Able to understand English and provide informed assent/consent
Exclusion Criteria
* Actively receiving cancer treatment
* Does not own a smartphone with a data plan
* Visual or cognitive impairments causing inability to read, complete or sign the consent form and survey
* Participants with diagnosis of thyroid cancer (due to differences in physical, psychological, emotional, and social effects)
* Presence of a psychiatric disorder that is not managed/unstable or suicidal ideation/actuation in preceding 12 months
* Currently meeting physical activity requirements per American Cancer Society guidelines (150 or more minutes per week of moderate to vigorous physical activity)
13 Years
39 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Iowa
OTHER
Lucas Carr
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Lucas Carr
Associate Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Lucas Carr, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Iowa
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Iowa
Iowa City, Iowa, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
201907702
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.